Individualized vaginal applicator for stage IIb primary vaginal adenocarcinoma: A case report

doi:10.5306/wjco.v15.i8.1102

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1138)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

HTML

558

Figures (1-6)

126

Sum=716

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

114

Download

128

Sum=242

Publishing Process of This Article

Item

Count

Browse

Download

105

Sum=152

Aug 24, 2024 (publication date) through Dec 20, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. Aug 24, 2024; 15(8): 1102-1109
Published online Aug 24, 2024. doi: 10.5306/wjco.v15.i8.1102

Full Size Figure Download Figure

Figure 3 Morphological assessment. A: Pelvic enhanced computed tomography before treatment shows occupation of the left and anterior vaginal walls, maximum cross-section range 40 mm × 30 mm; B: Enhanced magnetic resonance image after 3 cycles of chemotherapy shows thickening of the left anterior vaginal wall; C: Enhanced magnetic resonance image after external irradiation.

Citation: Saijilafu, Gu YJ, Huang AW, Xu CF, Qian LW. Individualized vaginal applicator for stage IIb primary vaginal adenocarcinoma: A case report. World J Clin Oncol 2024; 15(8): 1102-1109
URL: https://www.wjgnet.com/2218-4333/full/v15/i8/1102.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i8.1102